Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upFátima Cardoso, Elżbieta Senkus, Sophia Zackrisson et al.|Annals of Oncology|2019Cited by 2.2k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFátima Cardoso, Martine Piccart, Peter A. Neijenhuis et al.|New England Journal of Medicine|2016Cited by 2k
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP InhibitionYasir H. Ibrahim, José Baselga, Aleix Prat et al.|Cancer Discovery|2012Cited by 622
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upFátima Cardoso, Elżbieta Senkus, S. Kyriakides et al.|Annals of Oncology|2019Cited by 544
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancerCristina Cruz, Violeta Serra, Marta Castroviejo‐Bermejo et al.|Annals of Oncology|2018Cited by 424